Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of desvenlafaxine succinate
(DVS) for treatment of moderate to severe vasomotor symptoms (VMS) that are associated with
menopause, and also to assess the effects of DVS on sleep parameters and health outcomes
indicators.